Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kucera MT"'
Autor:
Tiwari AK; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai CC; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Altar CA; Splice Therapeutics, 20271 Goldenrod Lane, Lab 2071, Germantown, MD, 20876, USA., Tanner JA; Myriad Neuroscience, Mason, OH, USA., Davies PE; Myriad Neuroscience, Mason, OH, USA., Traxler P; Myriad Neuroscience, Mason, OH, USA., Li J; Myriad Neuroscience, Mason, OH, USA., Cogan ES; Myriad Genetics, Salt Lake City, UT, USA., Kucera MT; Myriad Genetics, Salt Lake City, UT, USA., Gugila A; Myriad Neuroscience, Mason, OH, USA., Braganza N; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Emmerson H; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai G; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Müller DJ; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Levitan R; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Kloiber S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Daskalakis ZJ; Department of Psychiatry, UC San Diego, San Diego, CA, USA., Frey BN; Mood Disorders Treatment and Research Centre and Women's Health Concerns Clinic, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada., Bowen JM; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.; Program for Health System and Technology Evaluation, Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, Toronto General Hospital Research Institute (TGHRI), Hamilton, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network (UHN), Hamilton, Canada., Tarride JE; Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Health Science, McMaster University, Hamilton, ON, Canada.; Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada., Tytus R; Family Medicine, McMaster University, Hamilton, ON, Canada., Chandrasena R; Chatham-Kent Health Alliance, Chatham, ON, Canada., Voudouris N; Thornhill Medical Center, Toronto, ON, Canada., Taylor VH; Department of Psychiatry, University of Calgary, Hotchkiss Brain Institute, an Institute of the Cumming School of Medicine, Calgary, AB, Canada., Tempier R; Hôpital Montfort, Ottawa, ON, Canada.; Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada., Sharma V; Department of Psychiatry, Western University, London, ON, Canada., Vasudev A; Department of Psychiatry, Geriatric Psychiatry and Neurosciences, Western University, London, ON, Canada.; Integrative Psychiatry Lab, Parkwood Institute of Mental Health, London, ON, Canada., Dzongowski P; Milestone Research, London, ON, Canada., Pliamm L; Canadian Phase Onward Inc., Polyclinic Family and Specialty Medicine Facility, Polyclinic Family Health Group, Toronto, ON, Canada., Greenspoon T; Hamilton Community Health Centre, Hamilton, ON, Canada., Dechairo BM; Myriad Genetics, Salt Lake City, UT, USA., Kennedy JL; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. jim.kennedy@camh.ca.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2022 May 30; Vol. 12 (1), pp. 214. Date of Electronic Publication: 2022 May 30.
Autor:
Tiwari AK; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai CC; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Altar CA; Splice Therapeutics, 20271 Goldenrod Lane, Lab 2071, Germantown, MD, 20876, USA., Tanner JA; Myriad Neuroscience, Mason, OH, USA., Davies PE; Myriad Neuroscience, Mason, OH, USA., Traxler P; Myriad Neuroscience, Mason, OH, USA., Li J; Myriad Neuroscience, Mason, OH, USA., Cogan ES; Myriad Genetics, Salt Lake City, UT, USA., Kucera MT; Myriad Genetics, Salt Lake City, UT, USA., Gugila A; Myriad Neuroscience, Mason, OH, USA., Braganza N; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Emmerson H; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai G; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Müller DJ; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Levitan R; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Kloiber S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Daskalakis ZJ; Department of Psychiatry, UC San Diego, San Diego, CA, USA., Frey BN; Mood Disorders Treatment and Research Centre and Women's Health Concerns Clinic, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada., Bowen JM; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.; Program for Health System and Technology Evaluation, Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, Toronto General Hospital Research Institute (TGHRI), Hamilton, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network (UHN), Hamilton, Canada., Tarride JE; Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Health Science, McMaster University, Hamilton, ON, Canada.; Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada., Tytus R; Family Medicine, McMaster University, Hamilton, ON, Canada., Chandrasena R; Chatham-Kent Health Alliance, Chatham, ON, Canada., Voudouris N; Thornhill Medical Center, Toronto, ON, Canada., Taylor VH; Department of Psychiatry, University of Calgary, Hotchkiss Brain Institute, an Institute of the Cumming School of Medicine, Calgary, AB, Canada., Tempier R; Hôpital Montfort, Ottawa, ON, Canada.; Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada., Sharma V; Department of Psychiatry, Western University, London, ON, Canada., Vasudev A; Department of Psychiatry, Geriatric Psychiatry and Neurosciences, Western University, London, ON, Canada.; Integrative Psychiatry Lab, Parkwood Institute of Mental Health, London, ON, Canada., Dzongowski P; Milestone Research, London, ON, Canada., Pliamm L; Canadian Phase Onward Inc., Polyclinic Family and Specialty Medicine Facility, Polyclinic Family Health Group, Toronto, ON, Canada., Greenspoon T; Hamilton Community Health Centre, Hamilton, ON, Canada., Dechairo BM; Myriad Genetics, Salt Lake City, UT, USA., Kennedy JL; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. jim.kennedy@camh.ca.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2022 Mar 14; Vol. 12 (1), pp. 101. Date of Electronic Publication: 2022 Mar 14.